Research, Innovation necessity for sustained growth of pharma sector: Mandaviya

Published On 2022-01-30 05:00 GMT   |   Update On 2022-01-30 05:01 GMT
Advertisement

New Delhi: Union Minister for Chemicals and Fertilizers Shri Mansukh Mandaviya has recently launched NIPER Research Portal along with Shri Bhagwanth Khuba, Minister of State for Chemicals and Fertilizers in presence of Dr V. K Paul, Member (Health), Niti Aayog.

National Institute of Pharmaceutical Education and Research (NIPER) Research Portal has been created with the aim to disseminate the information about all the NIPERs and their research activities, patents filed and Publication information at one place so that a industry and other stakeholders know about them.

Advertisement

The purpose of this portal is to authenticate availability of the research work that is ongoing. It will help other researchers and especially the industry to get in touch with the relevant organization so that they can work together and make the research more purposeful and meaningful. For long, research institutes have been working in silos or isolation. The research portal will try to bring together research institutions spread across different departments within government and also these institutions with industries. The Ministry of Chemicals and Fertilizers also requested all relevant research institutions like the Department of Biotechnology, Department of Scientific and Industrial Research, Ministry of AYUSH, ICMR etc., and even DRDO, where a lot of pharmaceuticals sector-related research takes place to join this portal.

Reiterating the vision of the Prime Minister Shri Narendra of Jai Jawan, Jai Kisan, Jai Vigyan and Jai Anusandhaan, Dr Mansukh Mandaviya said that Research & Development is one of the crucial pillars for a country's economy.

He said that we need to harness this energy of aspirations of all stakeholders and create a holistic ecosystem. Our expertise in generics can also be further expanded to other sectors, he added.

Pointing towards the importance of healthy competition both in Industry and Academia, the Union Minister noted that competition and demand is a necessity of research and innovation as this promotes quality ideas and solutions for our citizens. He stressed that Research and Innovation is a necessity for the sustained growth of pharmaceuticals sector.

The Minister stated that the country already has young talent and human resources, but we need to channelize them effectively through Industry-Academia cooperation. To enhance this industry–Academia collaboration, the Department of Pharmaceuticals has created this Research Portal to capture the research activities of all seven NIPERs, he informed. He said that that the platform inaugurated would help us in promoting this synergy and would be a boon for our industries, especially the MSME sector.

Shri Bhagwanth Khuba said India is the third-largest pharmaceutical manufacturing country and our vaccine development story is an example of effective cooperation among stakeholders. He said that the platform will track the research and tasks of all NIPERS. He further said that the Government is committed to promote research and innovation and this portal is a step in that direction.

Dr VK Paul recollected the key role played by NIPERs in India's health ecosystem. He requested the government to streamline the funding pipeline and expedite the budgets allocated. He urged the industry to provide support like the NIPERs research fund for priority areas. He also encouraged NIPERs to create a vibrant scientific community by engaging with stakeholders and mobilizing ideas of the young generation, promoting academic autonomy and delivering on their research goals.

Accentuating the importance of NIPER's Research Program, which focuses on the needs of the hour, the Secretary, Department of Pharmaceuticals, Ms S. Aparna said that the importance of Research and Innovation has never been more important and more apparent than in the last two years of the global pandemic. We have seen the need for new drugs, re-purposed drugs, safer drugs, more efficacious drugs and the most affordable drugs to help mankind, she added. Shri highlighted that the portal will promote research work that is more relevant to the current evolving need of the sector and the requirements of the patient community.

Read also: NIPER Mohali appoints Professor Dulal Panda as new director

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News